IL-33 activates group 2 innate lymphoid cell expansion and modulates endometriosis
Open Access
- 8 December 2021
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (23)
Abstract
Chronic inflammation and localized alterations in immune cell function are suspected to contribute to the progression of endometriosis and its associated symptoms. In particular, the alarmin IL-33 is elevated in the plasma, peritoneal fluid, and endometriotic lesions from patients with endometriosis; however, the exact role of IL-33 in the pathophysiology of endometriosis is not well understood. In this study, we demonstrate, in both humans and a murine model, that IL-33 contributes to the expansion of group 2 innate lymphoid cells (ILC2s), and this IL-33–induced ILC2 expansion modulates the endometriosis lesion microenvironment. Importantly, we show that IL-33 drives hallmarks of severe endometriosis, including elevated inflammation, lesion proliferation, and fibrosis, and that this IL-33–induced aggravation is mediated by ILC2s. Finally, we demonstrate the functionality of IL-33 neutralization as a promising and potentially novel therapeutic avenue for treating the debilitating symptoms of endometriosis.Keywords
Funding Information
- Canadian Institutes of Health Research (394340)
This publication has 50 references indexed in Scilit:
- Genome-Wide Association Study Link Novel Loci to EndometriosisPLOS ONE, 2013
- Endometriosis, a disease of the macrophageFrontiers in Immunology, 2013
- IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitizationJournal of Allergy and Clinical Immunology, 2013
- Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countriesFertility and Sterility, 2011
- IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway InflammationThe Journal of Immunology, 2009
- Hyperinnervation in Intestinal Deep Infiltrating EndometriosisJournal of Minimally Invasive Gynecology, 2009
- Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide productionBlood, 2009
- Macrophages Are Alternatively Activated in Patients with Endometriosis and Required for Growth and Vascularization of Lesions in a Mouse Model of DiseaseThe American Journal of Pathology, 2009
- IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated CytokinesImmunity, 2005
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996Fertility and Sterility, 1997